tesamorelin ipamorelin 6mg 3mg + (10/3 MG) 711.86 g/mol Sequence Tesamorelin TESAMORELIN + IPAMORELIN – Research

Injury Healing ( repairing tissues, joints, and muscles faster )

Funding The work was funded in part by an NUH seed fund grant from the Singapore Ministry of Education Academic Research Fund Tier 1 (Grant number R-183-000-448-114)

Tesamorelin is FDA approved but only for a specific HIV related fat redistribution condition, not for injury recovery

in 2017, more than 42 million Medicare beneficiaries are enrolled in Medicare Part D plans

Combining with AOD-9604 provides dual pathway activationgrowth hormone release via tesamorelin plus direct lipolytic action from AOD-9604though this requires careful physician oversight

Annu Rev Phytopathol 43:205227 Govrin EM, Levine A (2000) The hypersensitive response facilitates plant infection by the necrotrophic pathogen Botrytis cinerea